Pfizer’s Earnings Fall With Cooling Demand for Covid Products
Wall Street Journal
Excluding revenue from Comirnaty and Pfizer’s Covid-19 pill Paxlovid, the company’s top line increased 5%.
https://www.wsj.com/articles/pfizer-pfe-q1-earnings-report-2023-fbd3ad8